Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP699915.RA1lq5qGMdoen2l3TogaVVsCHbz6LF7TnJq6rUF3rH1Ho130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP699915.RA1lq5qGMdoen2l3TogaVVsCHbz6LF7TnJq6rUF3rH1Ho130_assertion type Assertion NP699915.RA1lq5qGMdoen2l3TogaVVsCHbz6LF7TnJq6rUF3rH1Ho130_head.
- NP699915.RA1lq5qGMdoen2l3TogaVVsCHbz6LF7TnJq6rUF3rH1Ho130_assertion wasGeneratedBy ECO_0000203 NP699915.RA1lq5qGMdoen2l3TogaVVsCHbz6LF7TnJq6rUF3rH1Ho130_provenance.
- NP699915.RA1lq5qGMdoen2l3TogaVVsCHbz6LF7TnJq6rUF3rH1Ho130_assertion wasDerivedFrom befree-2016 NP699915.RA1lq5qGMdoen2l3TogaVVsCHbz6LF7TnJq6rUF3rH1Ho130_provenance.
- NP699915.RA1lq5qGMdoen2l3TogaVVsCHbz6LF7TnJq6rUF3rH1Ho130_assertion SIO_000772 18952489 NP699915.RA1lq5qGMdoen2l3TogaVVsCHbz6LF7TnJq6rUF3rH1Ho130_provenance.
- NP699915.RA1lq5qGMdoen2l3TogaVVsCHbz6LF7TnJq6rUF3rH1Ho130_assertion evidence source_evidence_literature NP699915.RA1lq5qGMdoen2l3TogaVVsCHbz6LF7TnJq6rUF3rH1Ho130_provenance.
- NP699915.RA1lq5qGMdoen2l3TogaVVsCHbz6LF7TnJq6rUF3rH1Ho130_assertion description "[Loss of CTNNB1 (3p22) and gain of CDKN2D (19p13) were also significantly more frequent in lymph node metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP699915.RA1lq5qGMdoen2l3TogaVVsCHbz6LF7TnJq6rUF3rH1Ho130_provenance.